Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Pharmadrug Inc.
  6. News
  7. Summary
    BUZZ   CA71716W1059

PHARMADRUG INC.

(BUZZ)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PharmaDrug Reports Supply Deal with European Cannabis Extractor for Medical Grade THC Oil

05/14/2021 | 11:33am EDT


ę MT Newswires 2021
All news about PHARMADRUG INC.
07:50aPharmaDrug Advances Product and Clinical Development of Cepharanthine to Trea..
NE
06/07Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Net..
NE
05/17PharmaDrug's Super Smart Launches Online Retail Platform in the United States
NE
05/14PharmaDrug Reports Supply Deal with European Cannabis Extractor for Medical G..
MT
05/14PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medica..
NE
05/13PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grant..
NE
05/06PharmaDrug Initiates Preclinical Study of Cepharanthine to Both Broaden Its C..
NE
04/28PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevent..
NE
04/20PharmaDrug Advances Product and Clinical Development of Cepharanthine to Trea..
NE
03/16Pharmadrug Initiates DMT Research Activities via Collaboration with the Unive..
NE
More news
Financials
Sales 2020 0,68 M 0,56 M 0,56 M
Net income 2020 -5,15 M -4,18 M -4,18 M
Net cash 2020 3,28 M 2,66 M 2,66 M
P/E ratio 2020 -2,21x
Yield 2020 -
Capitalization 25,5 M 20,6 M 20,7 M
EV / Sales 2019 7,68x
EV / Sales 2020 18,3x
Nbr of Employees -
Free-Float 94,5%
Chart PHARMADRUG INC.
Duration : Period :
Pharmadrug Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Daniel Cohen Chairman & Chief Executive Officer
Keith Li Chief Financial Officer & Secretary
Paul Van Slyke Chief Scientific Officer
Robert Schwartz Independent Director
Paul Gerard Joseph McClory Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PHARMADRUG INC.-6.25%21
JOHNSON & JOHNSON4.10%431 456
ROCHE HOLDING AG12.99%328 650
PFIZER, INC.7.09%220 661
NOVARTIS AG3.00%210 615
ABBVIE INC.7.07%202 639